Follow
Jan Hontelez
Jan Hontelez
Erasmus MC
Verified email at erasmusmc.nl
Title
Cited by
Cited by
Year
HIV treatment as prevention: systematic comparison of mathematical models of the potential impact of antiretroviral therapy on HIV incidence in South Africa
JW Eaton, LF Johnson, JA Salomon, T Bärnighausen, E Bendavid, ...
PLoS medicine 9 (7), e1001245, 2012
4162012
Population-level impact, herd immunity, and elimination after human papillomavirus vaccination: a systematic review and meta-analysis of predictions from transmission-dynamic …
M Brisson, É Bénard, M Drolet, JA Bogaards, I Baussano, S Vänskä, M Jit, ...
The Lancet Public Health 1 (1), e8-e17, 2016
2652016
Health benefits, costs, and cost-effectiveness of earlier eligibility for adult antiretroviral therapy and expanded treatment coverage: a combined analysis of 12 mathematical …
JW Eaton, NA Menzies, J Stover, V Cambiano, L Chindelevitch, A Cori, ...
The Lancet Global Health 2 (1), e23-e34, 2014
2252014
Universal test and treat and the HIV epidemic in rural South Africa: a phase 4, open-label, community cluster randomised trial
CC Iwuji, J Orne-Gliemann, J Larmarange, E Balestre, R Thiebaut, ...
The lancet HIV 5 (3), e116-e125, 2018
2192018
The impact of antiretroviral treatment on the age composition of the HIV epidemic in sub-Saharan Africa
JAC Hontelez, SJ de Vlas, R Baltussen, ML Newell, R Bakker, F Tanser, ...
Aids 26, S19-S30, 2012
1702012
Elimination of HIV in South Africa through expanded access to antiretroviral therapy: a model comparison study
JAC Hontelez, MN Lurie, T Bärnighausen, R Bakker, R Baltussen, ...
PLoS medicine 10 (10), e1001534, 2013
1492013
Ageing with HIV in south africa
JAC Hontelez, MN Lurie, ML Newell, R Bakker, F Tanser, T Bärnighausen, ...
Aids 25 (13), 1665-1667, 2011
1032011
Priority setting for universal health coverage: we need evidence-informed deliberative processes, not just more evidence on cost-effectiveness
R Baltussen, MP Jansen, E Mikkelsen, N Tromp, J Hontelez, L Bijlmakers, ...
International journal of health policy and management 5 (11), 615, 2016
1012016
HIV treatment as prevention: models, data, and questions—towards evidence-based decision-making
HIV Modelling Consortium Treatment as Prevention Editorial Writing Group
PLoS Medicine 9 (7), e1001259, 2012
952012
Costs, effects and cost‐effectiveness of breast cancer control in Ghana
SG Zelle, KM Nyarko, WK Bosu, M Aikins, LM Niëns, JA Lauer, ...
Tropical Medicine & International Health 17 (8), 1031-1043, 2012
932012
Time and money: the true costs of health care utilization for patients receiving ‘free’HIV/TB care and treatment in rural KwaZulu-Natal
N Chimbindi, J Bor, ML Newell, F Tanser, R Baltusen, J Hontelez, ...
Journal of acquired immune deficiency syndromes (1999) 70 (2), e52, 2015
882015
The impact of the new WHO antiretroviral treatment guidelines on HIV epidemic dynamics and cost in South Africa
JAC Hontelez, SJ De Vlas, F Tanser, R Bakker, T Bärnighausen, ...
PloS one 6 (7), e21919, 2011
702011
Concerted efforts to control or eliminate neglected tropical diseases: how much health will be gained?
SJ de Vlas, WA Stolk, EA le Rutte, JAC Hontelez, R Bakker, DJ Blok, ...
PLoS neglected tropical diseases 10 (2), e0004386, 2016
642016
Assessment of epidemic projections using recent HIV survey data in South Africa: a validation analysis of ten mathematical models of HIV epidemiology in the antiretroviral …
JW Eaton, N Bacaër, A Bershteyn, V Cambiano, A Cori, RE Dorrington, ...
The Lancet Global Health 3 (10), e598-e608, 2015
592015
Long-term financing needs for HIV control in sub-Saharan Africa in 2015–2050: a modelling study
R Atun, AY Chang, O Ogbuoji, S Silva, S Resch, J Hontelez, ...
BMJ open 6 (3), e009656, 2016
522016
Balancing efficiency, equity and feasibility of HIV treatment in South Africa–development of programmatic guidance
R Baltussen, E Mikkelsen, N Tromp, AK Hurtig, J Byskov, Ø Olsen, ...
Cost Effectiveness and Resource Allocation 11 (1), 1-9, 2013
502013
Looking upstream to prevent HIV transmission: can interventions with sex workers alter the course of HIV epidemics in Africa as they did in Asia?
R Steen, JAC Hontelez, A Veraart, RG White, SJ de Vlas
Aids 28 (6), 891-899, 2014
492014
The socioeconomic benefit to individuals of achieving the 2020 targets for five preventive chemotherapy neglected tropical diseases
WK Redekop, EJ Lenk, M Luyendijk, C Fitzpatrick, L Niessen, WA Stolk, ...
PLoS neglected tropical diseases 11 (1), e0005289, 2017
482017
Evidence for scaling up HIV treatment in sub-Saharan Africa: a call for incorporating health system constraints
E Mikkelsen, JAC Hontelez, MPM Jansen, T Bärnighausen, K Hauck, ...
PLoS medicine 14 (2), e1002240, 2017
462017
Changing HIV treatment eligibility under health system constraints in sub-Saharan Africa: investment needs, population health gains, and cost-effectiveness
JAC Hontelez, AY Chang, O Ogbuoji, SJ de Vlas, T Bärnighausen, R Atun
AIDS (London, England) 30 (15), 2341, 2016
462016
The system can't perform the operation now. Try again later.
Articles 1–20